NCT04760132 - National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE) | Biotech Hunter

Enrollment

7,600

Participants

Timeline

Start Date

February 8, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions

SARS-CoV Infection

Interventions

BIOLOGICAL

COMIRNATY - BioNTech Manufacturing GmbH

Vaccination as part of the the Danish national government programme

BIOLOGICAL

COVID-19 Vaccine Moderna dispersion for injection - MODERNA BIOTECH

Vaccination as part of the the Danish national government programme

BIOLOGICAL

COVID-19 Vaccine AstraZeneca suspension for injection

Vaccination as part of the the Danish national government programme

Trial Locations (5)

Hvidovre Hospital, Hvidovre

Sjællandsuniversitetshospital, Roskilde

Odense Universityhospital, Odense

Aarhus Universitetshospital, Skejby, Aarhus

Aalborg Universityhospital Syd, Aalborg

All Listed Sponsors

collaborator

Ministry of the Interior and Health, Denmark

OTHER_GOV

lead

Jens D Lundgren, MD

OTHER